It has been 12 yr since the publication of the last World Health Organization (WHO)
classification of tumours of the prostate and bladder. During this time, significant new …

Context Urothelial carcinoma can exhibit a wide range of variant morphologies. Many
variants present diagnostic challenges and carry clinical implications that inform prognosis …

Histological and molecular analyses of urothelial carcinoma often reveal intratumoural and
intertumoural heterogeneity at the genomic, transcriptional and cellular levels. Despite the …

In the past 10 years evidence for the clinical relevance of variant histology in urinary bladder
cancer has been increasing. This increase has resulted in new classifications of urothelial …

It is well established that invasive urothelial carcinoma, involving the urinary bladder and
renal pelvis, has marked propensity for divergent differentiation. In recent years, several …

Bladder cancer can be classified histologically as urothelial or non-urothelial. Urothelial
cancer has a propensity for divergent differentiation, which has increasingly been …

Micropapillary carcinoma or a micropapillary carcinoma component has been reported in
the ovary, breast, and urinary bladder and is generally thought to have prognostic …

Patient risk stratification is essential for optimal management of patients with bladder cancer.
Risk status determines the application and timing of therapeutic interventions such as repeat …

BACKGROUND Micropapillary bladder carcinoma is a rare variant of urothelial carcinoma.
To improve understanding of this disease, the authors performed a retrospective review of …

Background Progression of conventional urothelial carcinoma of the bladder to a tumor with
unique microscopic features referred to as micropapillary carcinoma is coupled with …